A.R. Chadeayne

436 total citations
35 papers, 330 citations indexed

About

A.R. Chadeayne is a scholar working on Clinical Psychology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, A.R. Chadeayne has authored 35 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Clinical Psychology, 24 papers in Organic Chemistry and 14 papers in Molecular Biology. Recurrent topics in A.R. Chadeayne's work include Psychedelics and Drug Studies (26 papers), Chemical synthesis and alkaloids (20 papers) and Alkaloids: synthesis and pharmacology (11 papers). A.R. Chadeayne is often cited by papers focused on Psychedelics and Drug Studies (26 papers), Chemical synthesis and alkaloids (20 papers) and Alkaloids: synthesis and pharmacology (11 papers). A.R. Chadeayne collaborates with scholars based in United States, Germany and Belgium. A.R. Chadeayne's co-authors include David R. Manke, James A. Golen, Peter T. Wolczanski, Emil B. Lobkovsky, Grant C. Glatfelter, Michael H. Baumann, Abhishek Dube, J. R. Engstrom, Alexander M. Sherwood and Brian G. Reid and has published in prestigious journals such as Journal of the American Chemical Society, SHILAP Revista de lepidopterología and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

A.R. Chadeayne

30 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.R. Chadeayne United States 11 217 202 88 74 53 35 330
Radek Jurok Czechia 10 186 0.9× 163 0.8× 59 0.7× 62 0.8× 20 0.4× 19 355
Robert B. Kargbo United States 15 591 2.7× 195 1.0× 259 2.9× 40 0.5× 48 0.9× 34 801
Bronislav Jurásek Czechia 12 99 0.5× 49 0.2× 55 0.6× 53 0.7× 18 0.3× 30 330
James B. C. Mack United States 10 347 1.6× 58 0.3× 67 0.8× 103 1.4× 12 0.2× 12 624
Paul J. Dobrowolski United States 11 111 0.5× 79 0.4× 108 1.2× 74 1.0× 24 0.5× 18 473
Dallas K. Bates United States 14 372 1.7× 37 0.2× 114 1.3× 29 0.4× 9 0.2× 34 501
Ju‐Tsung Liu Taiwan 17 473 2.2× 26 0.1× 110 1.3× 23 0.3× 11 0.2× 26 685
Adam S. Hogendorf Poland 11 114 0.5× 24 0.1× 113 1.3× 64 0.9× 19 0.4× 21 268
Fu‐Lian Hsu United States 12 199 0.9× 14 0.1× 99 1.1× 57 0.8× 41 0.8× 37 439
Yuri Shafran Russia 11 113 0.5× 110 0.5× 65 0.7× 45 0.6× 6 0.1× 24 361

Countries citing papers authored by A.R. Chadeayne

Since Specialization
Citations

This map shows the geographic impact of A.R. Chadeayne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.R. Chadeayne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.R. Chadeayne more than expected).

Fields of papers citing papers by A.R. Chadeayne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.R. Chadeayne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.R. Chadeayne. The network helps show where A.R. Chadeayne may publish in the future.

Co-authorship network of co-authors of A.R. Chadeayne

This figure shows the co-authorship network connecting the top 25 collaborators of A.R. Chadeayne. A scholar is included among the top collaborators of A.R. Chadeayne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.R. Chadeayne. A.R. Chadeayne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chadeayne, A.R., et al.. (2023). Synthesis and structure of 4-hydroxy-N-isopropyltryptamine (4-HO-NiPT) and its precursors. Acta Crystallographica Section E Crystallographic Communications. 79(4). 280–286. 2 indexed citations
3.
Le, Alexander, et al.. (2023). N-Cyclohexyltryptamine: freebase, bromide and fumarate. Acta Crystallographica Section E Crystallographic Communications. 79(8). 752–756.
4.
Chadeayne, A.R., et al.. (2023). N-Methylserotonin hydrogen oxalate. SHILAP Revista de lepidopterología. 8(5). x230378–x230378. 1 indexed citations
5.
Chadeayne, A.R., et al.. (2023). Bis(4-acetoxy-N-ethyl-N-n-propyltryptammonium) fumarate–fumaric acid (1/1). SHILAP Revista de lepidopterología. 8(9). x230779–x230779.
6.
Bartram, Stefan, Markus Gressler, A.R. Chadeayne, et al.. (2023). A „Magic Mushroom“ Multi‐Product Sesquiterpene Synthase. ChemBioChem. 24(21). e202300511–e202300511. 4 indexed citations
7.
Glatfelter, Grant C., Eline Pottie, John S. Partilla, et al.. (2022). Structure–Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice. ACS Pharmacology & Translational Science. 5(11). 1181–1196. 56 indexed citations
8.
Chadeayne, A.R., et al.. (2022). Crystal structure of serotonin. Acta Crystallographica Section E Crystallographic Communications. 78(4). 365–368. 3 indexed citations
9.
Chadeayne, A.R., et al.. (2022). Bis(oxotremorine) fumarate bis(fumaric acid). SHILAP Revista de lepidopterología. 7(4). x220364–x220364.
10.
Sherwood, Alexander M., et al.. (2022). The crystal structure of baeocystin. Acta Crystallographica Section E Crystallographic Communications. 78(6). 550–553. 5 indexed citations
11.
Chadeayne, A.R., et al.. (2021). Bufotenidinium iodide. SHILAP Revista de lepidopterología. 6(2). x210123–x210123. 3 indexed citations
12.
Chadeayne, A.R., et al.. (2021). 2,5-Dimethylbufotenine and 2,5-dimethylbufotenidine: novel derivatives of natural tryptamines found in Bufo alvarius toads. Acta Crystallographica Section E Crystallographic Communications. 77(2). 190–194. 6 indexed citations
13.
Chadeayne, A.R., et al.. (2021). The crystalline forms of nine hydrochloride salts of substituted tryptamines. Acta Crystallographica Section C Structural Chemistry. 77(10). 615–620. 3 indexed citations
14.
Chadeayne, A.R., et al.. (2020). DMT analogues: N-ethyl-N-propyltryptamine and N-allyl-N-methytryptamine as their hydrofumarate salts. Acta Crystallographica Section E Crystallographic Communications. 76(8). 1201–1205. 4 indexed citations
15.
Chadeayne, A.R., et al.. (2020). 5-MeO-DALT: the freebase of N,N-diallyl-5-methoxytryptamine. SHILAP Revista de lepidopterología. 5(4). x200498–x200498. 6 indexed citations
16.
Chadeayne, A.R., et al.. (2020). Norpsilocin: freebase and fumarate salt. Acta Crystallographica Section E Crystallographic Communications. 76(4). 589–593. 12 indexed citations
17.
Chadeayne, A.R., et al.. (2020). Bis(4-hydroxy-N-isopropyl-N-methyltryptammonium) fumarate: a new crystalline form of miprocin. Acta Crystallographica Section E Crystallographic Communications. 76(4). 514–517. 10 indexed citations
18.
Rasapalli, Sivappa, et al.. (2020). The hydrochloride salt of 4-hydroxy-N,N-di-n-propyltryptamine (4-HO-DPT). SHILAP Revista de lepidopterología. 5(11). x201546–x201546. 3 indexed citations
19.
Chadeayne, A.R., James A. Golen, & David R. Manke. (2019). Bis(4-acetoxy-N,N-dimethyltryptammonium) fumarate: a new crystalline form of psilacetin, an alternative to psilocybin as a psilocin prodrug. Acta Crystallographica Section E Crystallographic Communications. 75(6). 900–902. 17 indexed citations
20.
Chadeayne, A.R., et al.. (2019). The fumarate salts of the N-isopropyl-N-methyl derivatives of DMT and psilocin. Acta Crystallographica Section E Crystallographic Communications. 75(9). 1316–1320. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026